Clearance of intravitreal voriconazole. 2007

Ying-Cheng Shen, and Mei-Yen Wang, and Chun-Yuan Wang, and Tsun-Chung Tsai, and Hin-Yeung Tsai, and Yi-Fen Lee, and Li-Chen Wei
Department of Ophthalmology, Taichung Veterans General Hospital, Taiwan, Republic of China.

Purpose To investigate the elimination rate of voriconazole after intravitreal injection in rabbits. METHODS Intravitreal injections of 35 microg/0.1 mL voriconazole were administered to rabbits. Vitreous and aqueous humor levels of voriconazole were determined at selected time intervals (1, 2, 4, 8, 16, 24, and 48 hours), and the in vitreous half-life was calculated. Four to six eyes per time point after injection were enucleated and immediately stored at -80 degrees C. Aqueous humor samples were withdrawn before enucleation, and vitreous samples were obtained from ocular dissection and isolation at various time intervals. Voriconazole concentrations in vitreous and aqueous humor were assayed with high-performance liquid chromatography (HPLC). RESULTS The concentration of intravitreal voriconazole at various time points exhibited exponential decay with a half-life of 2.5 hours. The mean vitreous concentration was 18.912 +/- 2.058 microg/mL 1 hour after intravitreal injection; this declined to 0.292 +/- 0.090 microg/mL at 16 hours. The mean aqueous concentration was much lower and showed a decline from 0.240 +/- 0.051 microg/mL at 1 hour to undetectable levels 8 hours after injection. CONCLUSIONS Vitreous concentrations achieved during the first 8 hours were greater than the previously reported minimum inhibitory concentrations (MICs) of organisms most involved in fungal endophthalmitis. A rapid decline of intravitreal concentration suggests that supplementation of intraocular voriconazole to maintain therapeutic levels may therefore be required in clinical settings. Further studies are needed to determine the elimination rate of voriconazole after intravitreal injection in humans.

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001082 Aqueous Humor The clear, watery fluid which fills the anterior and posterior chambers of the eye. It has a refractive index lower than the crystalline lens, which it surrounds, and is involved in the metabolism of the cornea and the crystalline lens. (Cline et al., Dictionary of Visual Science, 4th ed, p319) Aqueous Flare,Intraocular Fluid,Aqueous Flares,Aqueous Humors,Flare, Aqueous,Fluid, Intraocular,Fluids, Intraocular,Humor, Aqueous,Humors, Aqueous,Intraocular Fluids
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

Ying-Cheng Shen, and Mei-Yen Wang, and Chun-Yuan Wang, and Tsun-Chung Tsai, and Hin-Yeung Tsai, and Yi-Fen Lee, and Li-Chen Wei
January 2006, Investigative ophthalmology & visual science,
Ying-Cheng Shen, and Mei-Yen Wang, and Chun-Yuan Wang, and Tsun-Chung Tsai, and Hin-Yeung Tsai, and Yi-Fen Lee, and Li-Chen Wei
January 2005, Transactions of the American Ophthalmological Society,
Ying-Cheng Shen, and Mei-Yen Wang, and Chun-Yuan Wang, and Tsun-Chung Tsai, and Hin-Yeung Tsai, and Yi-Fen Lee, and Li-Chen Wei
November 2004, Archives of ophthalmology (Chicago, Ill. : 1960),
Ying-Cheng Shen, and Mei-Yen Wang, and Chun-Yuan Wang, and Tsun-Chung Tsai, and Hin-Yeung Tsai, and Yi-Fen Lee, and Li-Chen Wei
January 2003, Transactions of the American Ophthalmological Society,
Ying-Cheng Shen, and Mei-Yen Wang, and Chun-Yuan Wang, and Tsun-Chung Tsai, and Hin-Yeung Tsai, and Yi-Fen Lee, and Li-Chen Wei
August 2011, International ophthalmology,
Ying-Cheng Shen, and Mei-Yen Wang, and Chun-Yuan Wang, and Tsun-Chung Tsai, and Hin-Yeung Tsai, and Yi-Fen Lee, and Li-Chen Wei
June 1985, Ophthalmic surgery,
Ying-Cheng Shen, and Mei-Yen Wang, and Chun-Yuan Wang, and Tsun-Chung Tsai, and Hin-Yeung Tsai, and Yi-Fen Lee, and Li-Chen Wei
July 1981, American journal of ophthalmology,
Ying-Cheng Shen, and Mei-Yen Wang, and Chun-Yuan Wang, and Tsun-Chung Tsai, and Hin-Yeung Tsai, and Yi-Fen Lee, and Li-Chen Wei
January 2011, Internal medicine (Tokyo, Japan),
Ying-Cheng Shen, and Mei-Yen Wang, and Chun-Yuan Wang, and Tsun-Chung Tsai, and Hin-Yeung Tsai, and Yi-Fen Lee, and Li-Chen Wei
January 2020, Case reports in ophthalmology,
Ying-Cheng Shen, and Mei-Yen Wang, and Chun-Yuan Wang, and Tsun-Chung Tsai, and Hin-Yeung Tsai, and Yi-Fen Lee, and Li-Chen Wei
July 2006, Ophthalmology,
Copied contents to your clipboard!